CD34 and myelodysplastic syndrome: This effect is also consistent with our prior results of JMJD3 inhibition in MDS BM CD34+ cells [31], and that inhibition of TRAF6 in both murine and human HSPCs could prompt erythroid differentiation [8], [37].